Background Before the COVID-19 pandemic, coronaviruses caused two noteworthy
outbreaks: severe acute respiratory syndrome (SARS), starting in 2002, and Middle East …

Background Neuropsychiatric presentations of monkeypox (MPX) infection have not been
well characterised, despite evidence of nervous system involvement associated with the …

Background Concerns regarding potential neurological complications of COVID-19 are
being increasingly reported, primarily in small series. Larger studies have been limited by …

Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness …

Antibodies to the N-methyl-d-aspartate subtype of glutamate receptor have been associated
with a newly-described encephalopathy that has been mainly identified in young females …

This review concentrates on the evidence for autoantibodies to cell surface synaptic proteins
in psychosis and schizophrenia. We and others have recently found antibodies to the N …

Abstract Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus
disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to …

Schizophrenia is a common, heterogenous and complex disorder with unknown aetiology
[1]. There is established evidence for N-methyl-D-aspartate receptor (NMDAR) hypofunction …

Introduction Post-COVID-19 complications require simultaneous characterisation and
management to plan policy and health system responses. We describe the 12-month …

The British Association for Psychopharmacology developed an evidence-based consensus
guideline on the management of catatonia. A group of international experts from a wide …